SABS SAB Biotherapeutics, Inc. logo

SABS SAB Biotherapeutics, Inc.

Healthcare
$3.79+0.00%OpenMarket Cap: $36.2M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

7

Dispositions

1

Buy/Sell Ratio

7.00

Net Shares

+14,879,012

Shares Acquired

14,880,000

Shares Disposed

988

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed Mar 25Kropotova Alexandraofficer: CHIEF MEDICAL OFFICERSell988$0.0043,296
Thu Feb 05To Lucyofficer: See RemarksSell2,400,000$4.452,400,000
Thu Feb 05Sullivan Eddie Joedirector, officer: PRESIDENTSell3,000,000$4.453,000,000
Thu Feb 05Reich Samuel Jdirector, officer: CEOSell4,800,000$4.454,800,000
Thu Feb 05Kropotova Alexandraofficer: CHIEF MEDICAL OFFICERSell2,400,000$4.452,400,000
Thu Feb 05Bausch Christoph Lawrenceofficer: CHIEF OPERATING OFFICERSell1,800,000$4.451,800,000
Wed Jan 07ZACCARDELLI DAVIDdirectorSell240,000$3.74240,000
Wed Jan 07ZACCARDELLI DAVIDSell0$0.000
Wed Jan 07Jain RitadirectorSell240,000$3.74240,000
Wed Jan 07Jain RitaSell0$0.000
Thu Dec 18SKYLER JAY SdirectorSell150,000$3.99150,000